Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Marc M. Lemaitre, PhD
Principal at ML Consult
Speaker

Profile

I have a very long experience with oligonucleotide therapeutics, focusing on CMC. I have over 20 years of experience in the fields of Biotech research, production, QA, development in particular with oligonucleotides for therapeutic applications. As CEO of Girindus America [now Avecia Cincinnati, I supervised the manufacturing of more than 30 oligonucleotides for clinical trials. I authored several CMC parts IND and/or tIMPD.

Agenda Sessions

  • Drug Substance and Drug Product and How CMC Early in the Discovery Lifecycle Can Help

    09:10